DIAGNOSTIC CYTOPATHOLOGY
Note: The following journal information is for reference only. Please check the journal website for updated information prior to submission.
Journal Title
DIAGNOSTIC CYTOPATHOLOGY
DIAGN CYTOPATHOL
ISSN / eISSN
8755-1039 / 1097-0339
Aims and Scope
Diagnostic Cytopathology is intended to provide a forum for the exchange of information in the field of cytopathology, with special emphasis on the practical, clinical aspects of the discipline. The editors invite original scientific articles, as well as special review articles, feature articles, and letters to the editor, from laboratory professionals engaged in the practice of cytopathology. Manuscripts are accepted for publication on the basis of scientific merit, practical significance, and suitability for publication in a journal dedicated to this discipline. Original articles can be considered only with the understanding that they have never been published before and that they have not been submitted for simultaneous review to another publication.
Subject Area
MEDICAL LABORATORY TECHNOLOGY
PATHOLOGY
CiteScore
2.60
View Trend
CiteScore Ranking
Category | Quartile | Rank |
---|---|---|
Medicine - Pathology and Forensic Medicine | Q3 | #108/208 |
Medicine - Histology | Q3 | #40/62 |
Web of Science Core Collection
Science Citation Index Expanded (SCIE) | Social Sciences Citation Index (SSCI) |
---|---|
Indexed | - |
Category (Journal Citation Reports 2024) | Quartile |
---|---|
MEDICAL LABORATORY TECHNOLOGY | Q4 |
PATHOLOGY | Q4 |
H-index
61
Country/Area of Publication
UNITED STATES
Publisher
Wiley-Liss Inc.
Publication Frequency
Monthly
Year Publication Started
1985
Annual Article Volume
147
Open Access
NO
Contact
WILEY-LISS, DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, USA, NJ, 07030
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now